Syngene International Limited (NSE: SYNGENE)

Market Cap	361.01B
Revenue (ttm)	34.70B
Net Income (ttm)	4.92B
Shares Out	401.28M
EPS (ttm)	12.25
PE Ratio	73.45
Forward PE	62.65
Dividend	1.25 (0.14%)
Ex-Dividend Date	Jun 28, 2024

Volume	1,179,513
Open	905.00
Previous Close	906.65
Day's Range	895.30 - 910.00
52-Week Range	607.65 - 924.00
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 18, 2024

About Syngene International

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, prot...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1993
• Employees: 6,510
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SYNGENE

Financial Performance

In 2023, SYNGENE's revenue was 34.89 billion, an increase of 9.26% compared to the previous year's 31.93 billion. Earnings were 5.10 billion, an increase of 9.82%.